Navigation Links
Dominion Diagnostics Introduces CARD™: The Next-Generation Clinical Laboratory Diagnostics Tool for Addiction Treatment
Date:6/15/2010

NORTH KINGSTOWN, R.I., June 15 /PRNewswire/ -- At the forefront of the ongoing effort to enhance addiction treatment outcomes, one leading Rhode Island Company has announced the next-generation clinical laboratory diagnostics tool designed to assist clinicians.  

Dominion Diagnostics (Dominion), a privately-held clinical urine drug testing laboratory, today announced the release of its new Comprehensive Analysis of Reported Drugs (CARD)™ results, a unique clinical laboratory reporting service that provides clinicians with accurate testing results and analytical feedback to augment the assessment and monitoring of an individual's drug use upon admission and throughout the course of addiction treatment.

Dominion developed its CARD™ reporting service to create a highly personalized clinical report by correlating an individual's prescribed medication use and self-reported drug misuse with its state-of-the-art diagnostic testing.

CARD™ utilizes laboratory results from validated quantitative urine drug testing profiles for commonly abused illicit and prescription drugs and/or their metabolites, as well as biological markers and commercial adulterant screening (i.e., creatinine, specific gravity, pH, and oxidants) to ensure specimen validity.   CARD™ employs a supplied list of prescribed treatment-related medications and self-reported non-prescribed drug misuse, along with documented pharmaceutical and pharmacokinetic references backed by Dominion's expert Clinical Services team of pharmacists.  

Dominion's CARD™ results provide data to support and measure a treatment program's ability to reduce morbidity in substance abuse, improve retention in treatment, and promote the use of evidence-based practice for individuals suffering from addiction and mental health disorders, in line with ongoing initiatives supported by the Substance Abuse and Mental Health Services Agency (SAMHSA).

"CARD™ is a new service that will assist clinicians in tailoring addiction treatment services to each individual, thus improving  treatment  retention and outcomes by providing a more complete picture of their clients' treatment progress," said Dominion's Vice President of Addiction Services, Mary Hauser, MA.  "It is the first objective laboratory reporting tool of its kind."

For treatment programs, CARD™ provides a mechanism for reporting summary data that reflects client's medication compliance and treatment progress on a quarterly or annual basis. This data can be used by treatment programs to report outcomes to a wide variety of private and governmental funding sources.    

ABOUT DOMINION DIAGNOSTICS

Dominion Diagnostics is a premier provider of comprehensive clinical quantitative urine drug testing, medication monitoring and support services nationwide. For over 13 years, Dominion has provided services to thousands of clients in a variety of medical specialties, including Addiction Treatment, Behavioral Health, Pain Medicine, Primary Care, and Hospital Systems.  Dominion is supported by a world-class team that shares a commitment to clinical and operational excellence.  For more information about Dominion, please visit www.dominiondiagnostics.com.

Media Contact:

Julie K. Lenahan, MBA, Director of Marketing, 401/667-0876, jlenahan@dominiondiagnostics.com


'/>"/>
SOURCE Dominion Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
3. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
4. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
7. Study of Pathwork Diagnostics Tissue of Origin Test Published in the Journal of Molecular Diagnostics: Investigates Test Reproducibility in Multiple Labs to Determine Primary Tumor in Cancer Cases
8. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
9. Siemens Healthcare Diagnostics Launches B12, Folate, and Ferritin Tests on Its Dimension vista Intelligent Lab System
10. Focus Diagnostics Launches Laboratory Test for Chikungunya Virus
11. Bertrand Study Finds Significant Value in Breast-Specific Gamma Imaging (BSGI) as an Adjunctive Procedure in Breast Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase of ... and an increase of 1.2% on an adjusted pro forma, ... quarter were $0.52 reported, a decrease of 47.5% from the ... over the prior year period , The Company increases ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today ...
(Date:4/28/2016)... 28, 2016 TapImmune,Inc. (TPIV), ... peptide and gene-based immunotherapeutics and vaccines for the treatment of ... at the 3rd Annual Growth Capital Expo to ... 2016 at Caesars Palace in Las Vegas, Nevada.  The ... May 4 th by Dr. John N. Bonfiglio ...
(Date:4/27/2016)... 2016   , ... Recurring Consumable Sales  Clinical sales grow 16% ... (Euronext: MKEA, OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary ... the first quarter ended March 31, 2016 and provided ... its commercial strategy. First Quarter 2016 Revenue ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... MedPro Waste Disposal, LLC ... service. MedPro now offers its mail back service for an all-inclusive rate. MedPro ... now able to provide service to all of the clients in the country who ...
(Date:5/2/2016)... Veendam, The Netherlands (PRWEB) , ... May 02, 2016 , ... ... Products is honored to announce that the new WHIMZEES Variety Value Boxes were selected ... EXPO 2016 New Product Showcase Award. , WHIMZEES natural dental chews for dogs ...
(Date:5/2/2016)... ... 02, 2016 , ... Dr. Rassouli, dentist in Orange County, CA ... the research, which was published in the “Journal of the American Geriatrics Society,” more ... million Americans have Alzheimer’s disease. The study found that dental problems may increase the ...
(Date:5/2/2016)... ... ... 2016 World Ultimate & Guts Championship (WUGC) Mixed roster was announced in February and Chris ... is being held in London, England this year from June 18-25. At the last WUGC ... in the women’s masters division, and a silver in the women’s division, so Mazur hopes ...
(Date:5/2/2016)... ... , ... According to an American Psychological Association article, the Centers ... the age of 18. Of those who survive, many still face effects as they ... In her new book, Lyah! Lyah! Pants on Fyah!, she shares stories from women ...
Breaking Medicine News(10 mins):